BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 27436875)

  • 1. Natural underlying mtDNA heteroplasmy as a potential source of intra-person hiPSC variability.
    Perales-Clemente E; Cook AN; Evans JM; Roellinger S; Secreto F; Emmanuele V; Oglesbee D; Mootha VK; Hirano M; Schon EA; Terzic A; Nelson TJ
    EMBO J; 2016 Sep; 35(18):1979-90. PubMed ID: 27436875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease-causing mitochondrial heteroplasmy segregated within induced pluripotent stem cell clones derived from a patient with MELAS.
    Folmes CD; Martinez-Fernandez A; Perales-Clemente E; Li X; McDonald A; Oglesbee D; Hrstka SC; Perez-Terzic C; Terzic A; Nelson TJ
    Stem Cells; 2013 Jul; 31(7):1298-308. PubMed ID: 23553816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mRNA Reprogramming of T8993G Leigh's Syndrome Fibroblast Cells to Create Induced Pluripotent Stem Cell Models for Mitochondrial Disorders.
    Grace HE; Galdun P; Lesnefsky EJ; West FD; Iyer S
    Stem Cells Dev; 2019 Jul; 28(13):846-859. PubMed ID: 31017045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. iPSC culture expansion selects against putatively actionable mutations in the mitochondrial genome.
    Kosanke M; Davenport C; Szepes M; Wiehlmann L; Kohrn T; Dorda M; Gruber J; Menge K; Sievert M; Melchert A; Gruh I; Göhring G; Martin U
    Stem Cell Reports; 2021 Oct; 16(10):2488-2502. PubMed ID: 34560000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced pluripotent stem cells derived from patients carrying mitochondrial mutations exhibit altered bioenergetics and aberrant differentiation potential.
    Meshrkey F; Scheulin KM; Littlejohn CM; Stabach J; Saikia B; Thorat V; Huang Y; LaFramboise T; Lesnefsky EJ; Rao RR; West FD; Iyer S
    Stem Cell Res Ther; 2023 Nov; 14(1):320. PubMed ID: 37936209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oocyte mitochondrial deletions and heteroplasmy in a bovine model of ageing and ovarian stimulation.
    Hammond ER; Green MP; Shelling AN; Berg MC; Peek JC; Cree LM
    Mol Hum Reprod; 2016 Apr; 22(4):261-71. PubMed ID: 26792869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Very low-level heteroplasmy mtDNA variations are inherited in humans.
    Guo Y; Li CI; Sheng Q; Winther JF; Cai Q; Boice JD; Shyr Y
    J Genet Genomics; 2013 Dec; 40(12):607-15. PubMed ID: 24377867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced pluripotent stem cells with a mitochondrial DNA deletion.
    Cherry AB; Gagne KE; McLoughlin EM; Baccei A; Gorman B; Hartung O; Miller JD; Zhang J; Zon RL; Ince TA; Neufeld EJ; Lerou PH; Fleming MD; Daley GQ; Agarwal S
    Stem Cells; 2013 Jul; 31(7):1287-97. PubMed ID: 23400930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human induced pluripotent stem cells harbor homoplasmic and heteroplasmic mitochondrial DNA mutations while maintaining human embryonic stem cell-like metabolic reprogramming.
    Prigione A; Lichtner B; Kuhl H; Struys EA; Wamelink M; Lehrach H; Ralser M; Timmermann B; Adjaye J
    Stem Cells; 2011 Sep; 29(9):1338-48. PubMed ID: 21732474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gaining Insight into Mitochondrial Genetic Variation and Downstream Pathophysiology: What Can i(PSCs) Do?
    Moreira JD; Gopal DM; Kotton DN; Fetterman JL
    Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relevance of mitochondrial DNA variants fluctuation during reprogramming and neuronal differentiation of human iPSCs.
    Palombo F; Peron C; Caporali L; Iannielli A; Maresca A; Di Meo I; Fiorini C; Segnali A; Sciacca FL; Rizzo A; Levi S; Suomalainen A; Prigione A; Broccoli V; Carelli V; Tiranti V
    Stem Cell Reports; 2021 Aug; 16(8):1953-1967. PubMed ID: 34329598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell reprogramming shapes the mitochondrial DNA landscape.
    Wei W; Gaffney DJ; Chinnery PF
    Nat Commun; 2021 Sep; 12(1):5241. PubMed ID: 34475388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade.
    Altomare C; Pianezzi E; Cervio E; Bolis S; Biemmi V; Benzoni P; Camici GG; Moccetti T; Barile L; Vassalli G
    Europace; 2016 Dec; 18(suppl 4):iv67-iv76. PubMed ID: 28011833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc Oxide Nanoparticles Induce Mitochondrial Biogenesis Impairment and Cardiac Dysfunction in Human iPSC-Derived Cardiomyocytes.
    Li Y; Li F; Zhang L; Zhang C; Peng H; Lan F; Peng S; Liu C; Guo J
    Int J Nanomedicine; 2020; 15():2669-2683. PubMed ID: 32368048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concise Review: Heteroplasmic Mitochondrial DNA Mutations and Mitochondrial Diseases: Toward iPSC-Based Disease Modeling, Drug Discovery, and Regenerative Therapeutics.
    Hatakeyama H; Goto Y
    Stem Cells; 2016 Apr; 34(4):801-8. PubMed ID: 26850516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic rescue in pluripotent cells from patients with mtDNA disease.
    Ma H; Folmes CD; Wu J; Morey R; Mora-Castilla S; Ocampo A; Ma L; Poulton J; Wang X; Ahmed R; Kang E; Lee Y; Hayama T; Li Y; Van Dyken C; Gutierrez NM; Tippner-Hedges R; Koski A; Mitalipov N; Amato P; Wolf DP; Huang T; Terzic A; Laurent LC; Izpisua Belmonte JC; Mitalipov S
    Nature; 2015 Aug; 524(7564):234-8. PubMed ID: 26176921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial and nuclear disease panel (Mito-aND-Panel): Combined sequencing of mitochondrial and nuclear DNA by a cost-effective and sensitive NGS-based method.
    Abicht A; Scharf F; Kleinle S; Schön U; Holinski-Feder E; Horvath R; Benet-Pagès A; Diebold I
    Mol Genet Genomic Med; 2018 Nov; 6(6):1188-1198. PubMed ID: 30406974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial DNA Sequencing and Heteroplasmy Quantification by Next Generation Sequencing.
    Legati A; Ghezzi D; Viscomi C
    Methods Mol Biol; 2023; 2615():381-395. PubMed ID: 36807805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENs.
    Yang Y; Wu H; Kang X; Liang Y; Lan T; Li T; Tan T; Peng J; Zhang Q; An G; Liu Y; Yu Q; Ma Z; Lian Y; Soh BS; Chen Q; Liu P; Chen Y; Sun X; Li R; Zhen X; Liu P; Yu Y; Li X; Fan Y
    Protein Cell; 2018 Mar; 9(3):283-297. PubMed ID: 29318513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mutation m.13513G>A impairs cardiac function, favoring a neuroectoderm commitment, in a mutant-load dependent way.
    Galera-Monge T; Zurita-Díaz F; Garesse R; Gallardo ME
    J Cell Physiol; 2019 Nov; 234(11):19511-19522. PubMed ID: 30950033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.